eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Novartis Pharmaceuticals UK Ltd
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 03/08/2011
PIL EXELON Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change of manufacturer
Updated on 21/06/2011 and displayed until 03/08/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/06/2010 and displayed until 21/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 09/03/2009 and displayed until 03/06/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 20/06/2008 and displayed until 09/03/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 10/05/2006 and displayed until 20/06/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 19/01/2005 and displayed until 10/05/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 07/05/2004 and displayed until 19/01/2005
Reasons for adding or updating:
  • Change of manufacturer
Updated on 03/09/2003 and displayed until 07/05/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 10/06/2003 and displayed until 03/09/2003
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/12/2002 and displayed until 10/06/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC
Updated on 21/12/2001 and displayed until 24/12/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  rivastigmine hydrogen tartrate